IMARI (Interdisciplinary Meeting on Antimicrobial Resistance and Innovation) is a cross-sector meeting focused on advancing solutions to antimicrobial resistance by bringing together stakeholders from research, industry, clinical practice, policy and technology development.
Rather than a traditional scientific or clinical conference, IMARI is designed as an innovation-facing forum. The programme emphasises translation, implementation and collaboration across disciplines, with sessions addressing antimicrobial resistance, diagnostic innovation, anti-biofilm strategies, and the pathways required to move new technologies from concept to real-world impact.
IMARI places particular focus on the interfaces between science, product development, regulation and healthcare systems. By convening diverse perspectives in one setting, the meeting aims to identify practical barriers to innovation and explore strategies for accelerating the development and adoption of new antimicrobial and diagnostic solutions.
IMARI is relevant for researchers, innovators, industry leaders and policy stakeholders who are engaged in shaping the future of antimicrobial resistance management beyond single-discipline silos.